ArticlePloS one2017

Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer.

Alberto Peláez-García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.